Drug Database
Back to search

Switzerland· 69226001

Tacrocutan 0,03%, Salbe

A tacrolimus product containing tacrolimusum, registered in Switzerland by Dermapharm AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC D11AH01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTacrocutan 0,03%, SalbeATCD11AH01REGISTER NO.69226001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tacrolimusumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tacrolimus is registered in 12 of 19 countries.

Countries holding a registration under ATC D11AH01 (tacrolimus), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search tacrolimus products by name

Tacrolimus · ATC D11AH01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
tacrolimusum
Manufacturer
Dermapharm AG
Country
Switzerland (CH)
ATC code
D11AH01
ATC class
Tacrolimus
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680692260017
    Tb 30 g
    CHF 37.75

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tacrolimus in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tacrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Adport, Dailiport
  • Belgium · Adoport, Dailiport
  • Bulgaria · Програф
  • Cyprus · Prograf, Tacrolimus Accord
  • Czechia · Dailiport, Gecrol
  • Germany · Crilomus, Dailiport
  • Denmark · Adport, Dailiport
  • Estonia · Dailiport, Lebsanan
  • Spain · Adoport, Cellmune
  • Finland · Adport, Adport,
  • France · Adoport, Conferoport
  • United Kingdom (Northern Ireland) · Adoport, Ascezo
  • Greece · Atodrit-Dermo, Eczatope Derm
  • Croatia · Atezyrix, Dermitopic
  • Hungary · Prograf, Tacrolimus Stada
  • Ireland · Prograf, Tacrolimus Accord
  • Iceland · Advagraf, Dailiport
  • Italy · Adoport, Carelimus
  • Liechtenstein · Advagraf, Envarsus
  • Lithuania · Dailiport, Lebsanan
  • Luxembourg · Prograft, Sumilor
  • Latvia · Dailiport, Lebsanan
  • Malta · Prograf
  • Netherlands · Adport, Conferoport
  • Norway · Adport, Advagraf
  • Poland · Cidimus, Dailiport
  • Portugal · Adoport, Dermitopic
  • Romania · Prograf, Tacrolimus Sandoz
  • Sweden · Adport, Adport,
  • Slovenia · Adoport, Dailiport
  • Slovakia · Atezyrix, Dailiport

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fde1d17a-d55e-45a5-a8b9-8eb10da96707
GET /v1/drugs/fde1d17a-d55e-45a5-a8b9-8eb10da96707?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "tacrolimusum 0.3 mg",
  "valid_from": "2024-10-01",
  "limitations": "[{\"description\":\"Zur Behandlung mittelschwerer bis schwerer atopischer Dermatitis, falls die herkömmliche Behandlung nicht genügend wirksam ist oder Nebenwirkungen auftreten.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-10-01\"}]",
  "galenic_form": "Salbe 0.03 %",
  "therapeutic_area": null,
  "sl_inclusion_date": "2024-10-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about tacrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console